Table 1.
Demographics, sleep diary data, and overview of hypnotic use for the insomnia groups (means and SD are displayed)
| Chronic users n = 16 |
Infrequent users n = 16 |
Controls n = 16 |
|
|---|---|---|---|
| Age (years) | 62.6 (4.5) | 62.3 (6.2) | 62.9 (4.3) |
| Gender (n) | 7 females, 9 males | 8 females, 8 males | 7 females, 9 males |
| Pittsburgh Sleep Quality Index | 11.9 (3.7) | 12.4 (2.2) | 2.5 (1.5) |
| Sleep Onset Latency (min) | 43.6 (34.4) | 60.8 (64.3) | 14.0 (8.9) |
| Total Sleep Time (min) | 381 (103) | 306 (64) | 448 (26) |
| Sleep Efficiency (%) | 73.4 (14.1) | 65.6 (14.2) | 90.7 (7.3) |
| Number of users of hypnotics (%) | 16 (100 %) | 10 (62.5 %) | 0 (0 %) |
| Frequency of hypnotic use (nights per week) | 6.6 (1.0) | 1.1 (0.8) | 0 |
| Duration of hypnotic use (years) | 7.1 (5.0) | 7.8 (8.1) | 0 |
| Hypnotics and doses used (n) | |||
| Flurazepam 15 mg | 1 | 0 | – |
| Lorazepam 1 mg | 0 | 1 | – |
| Lormetazepam 0.5 mg | 1 | 0 | – |
| Lormetazepam 2 mg | 1 | 0 | – |
| Midazolam 7.5 mg | 3 | 0 | – |
| Nitrazepam 5 mg | 1 | 1 | – |
| Oxazepam 10 mg | 1 | 0 | – |
| Oxazepam 20 mg | 1 | 0 | – |
| Oxazepam 50 mg | 1 | 0 | – |
| Temazepam 10 mg | 2 | 4 | – |
| Temazepam 20 mg | 1 | 1 | – |
| Zopiclone 3.75 mg | 2 | 0 | – |
| Zopiclone 7.5 mg | 1 | 3 | – |